Clinical Study
Erlotinib and Concurrent Chemoradiation in Pretreated NSCLC Patients: Radiobiological Basis and Clinical Results
Figure 2
Overall survival according to clinical response after concurrent treatment with chemoradiation and TKIs therapy (). Legend: CR: complete response; PR: partial response; SD: stable disease; PD: progression disease.